Back to Results
First PageMeta Content
Pharmacology / Clinical research / Pharmaceutical industry / Medical statistics / Pharmacy / European Medicines Agency / Specialty / British National Formulary / Clinical trial / Pharmaceutical sciences / Health / Research


Enpr-EMA corporate feedback on Reg
Add to Reading List

Document Date: 2013-10-09 09:12:25


Open Document

File Size: 116,78 KB

Share Result on Facebook

City

London / /

Company

Collaborative Outcome Improvement Networks / Paediatric Research Networks / /

Continent

America / Europe / /

Country

United States / Netherlands / United Kingdom / /

Currency

USD / /

/

Facility

Great Ormond Street Children's hospital / Canary Wharf / /

IndustryTerm

trial protocols / supported child research networks / healthcare professionals / Cystic Fibrosis Therapeutics / particular products / active products / authorisation applications / clinical practice research network / healthcare systems / healthcare program / /

MedicalCondition

cancers / autoimmune disorders / chronic symptoms / hyper-lipidaemia and idiopathic hypertension / acute bronchiolitis / adult-like diseases / Crohn's / bronchiolitis / diseases / Colitis improvecarenow / common diseases / croup / /

Organization

American Board of Pediatrics / Great Ormond Street Children's hospital / European Medicines Agency / European Commission / FDA / Committee for Medicinal Products for Human Use / European Union / American Academy of Pediatrics / An / Enpr-EMA Secretariat / /

/

Position

advisors / pharmacist / physician / forward / General / JUDGE / /

ProvinceOrState

Massachusetts / /

PublishedMedium

the Pediatric Research / /

Technology

Proposed trial protocols / industry-initiated protocols / drug development / /

URL

www.ema.europa / /

SocialTag